GSK, Britain’s second-biggest drugmaker, has unveiled better-than-expected results for the first three months of the year, ahead of the planned July listing of its consumer healthcare division, which makes Sensodyne toothpaste and Panadol painkillers.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Go ahead